Search clinical trials for: Ruxolitinib Topical
Total 2655 results
-
University of ZurichIncyte CorporationNot yet recruitingExanthema | Lichenoid Skin Rashes Under Anti-PD1 Tumor Therapy
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Memorial Sloan Kettering Cancer CenterIncyte Corporation; Hackensack Meridian HealthCompletedNon-sclerotic Cutaneous Chronic Graft-versus-host DiseaseUnited States
-
LEO PharmaCompleted
-
First Affiliated Hospital of Zhejiang UniversityXiangya Hospital of Central South University; Second Affiliated Hospital, School... and other collaboratorsRecruitingHematologic Malignancy | Bronchiolitis Obliterans SyndromeChina
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Incyte CorporationCompleted
-
Beijing Friendship HospitalUnknownHemophagocytic LymphohistiocytosisChina
-
Julie NangiaIncyte Corporation; Translational Breast Cancer Research ConsortiumRecruitingDuctal Carcinoma In Situ | Atypical Ductal Hyperplasia | Atypical Lobular Hyperplasia | Lobular Carcinoma In SituUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingSevere Aplastic Anemia | Single Lineage Cytopenias, T-LGL | Hypoplastic MDSUnited States
-
Qilu Hospital of Shandong UniversityRecruiting
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Thomas Jefferson University; Cornell UniversityRecruiting
-
Children's Hospital Medical Center, CincinnatiCompletedSolid Organ Transplant | Acute-graft-versus-host Disease | Chronic Graft-versus-host-diseaseUnited States
-
University of RochesterIncyte CorporationActive, not recruiting
-
Aaron R. MangoldCompletedNecrobiosis LipoidicaUnited States
-
Novartis PharmaceuticalsTerminatedPrimary MyelofibrosisSpain, Germany, Italy
-
Children's Hospital Medical Center, CincinnatiRecruitingBronchiolitis Obliterans (BO) | Hematopoietic Stem Cell Transplant (HSCT)United States
-
University of JenaCompleted
-
University of Michigan Rogel Cancer CenterCompletedHemophagocytic Syndrome (HPS)United States
-
Margherita MaffioliUnknown
-
University of PittsburghWithdrawnHead and Neck Squamous Cell Carcinoma
-
Sichuan UniversityNot yet recruitingGVHD | Acute Stem Cell Transplant ComplicationsChina
-
Multinational Center for Quality of Life Research...Not yet recruiting
-
University of RochesterIncyte CorporationCompletedDiscoid Lupus ErythematosusUnited States
-
Tianjin Medical University General HospitalWithdrawnNeuromyelitis Optica Spectrum Disorder RelapseChina
-
Qilu Hospital of Shandong UniversityCompleted
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis | Post-Polycythemia Vera-MyelofibrosisBelgium, Italy, Spain, Bulgaria, Turkey, Greece, Russian Federation, Austria, Canada, Japan, Germany
-
Kantonsspital AarauNovartis; University Hospital, Basel, Switzerland; Clinical Trial Unit, University...TerminatedCancer CachexiaSwitzerland
-
Novartis PharmaceuticalsAvailable
-
Novartis PharmaceuticalsAvailablePrimary Myelofibrosis (PMF) | Polycythemia Vera (PV) | Post Polycythemia Myelofibrosis (PPV MF) | Thrombocythemia Myelofibrosis (PET-MF) | Severe/Very Severe COVID-19 Illness | Steroid Refractory Acute Graft Versus Host Disease (SR aGVHD) | Steroid Refractory Chronic Graft Versus Host Disease...
-
Columbia UniversityIncyte CorporationActive, not recruitingAdvanced Cutaneous Squamous Cell CarcinomaUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)
-
Incyte CorporationNo longer available
-
University Health Network, TorontoTerminatedCOVID-19 | PneumoniaCanada
-
Stefanie Sarantopoulos, MD, PhD.National Institutes of Health (NIH); Incyte Corporation; Rigel PharmaceuticalsNot yet recruitingChronic Graft Versus Host DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; Incyte CorporationRecruitingMyelofibrosis Due to and Following Polycythemia VeraUnited States
-
Novartis PharmaceuticalsActive, not recruitingGraft vs Host DiseaseJapan, Slovakia, Taiwan, Spain, Korea, Republic of, Thailand, Canada, Russian Federation, Italy, Turkey, India, Czechia, Brazil, Switzerland
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingT-cell Large Granular Lymphocyte Leukemia | T-cell Lymphomas | T-cell Prolymphocytic Leukemia | NK-Cell LymphomasUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Columbia UniversityLocks of Love; Alopecia Areata Initiative - Gates FoundationCompletedAlopecia AreataUnited States
-
Novartis PharmaceuticalsCompletedMyelofibrosisBelgium, Colombia, Canada, Italy, Spain, Austria, Germany, Czechia, Thailand, Hungary, Greece, Argentina, Brazil, Israel, Russian Federation, Mexico, Portugal, South Africa, Tunisia, Slovakia, Saudi Arabia, Poland, Algeria, Ireland, Mor...
-
Incyte CorporationCompletedMyelofibrosisUnited States
-
Novartis PharmaceuticalsNot yet recruitingSteroid-refractory Acute Graft Versus Host Disease
-
Novartis PharmaceuticalsRecruitingGraft-versus-Host DiseaseKorea, Republic of
-
Massachusetts General HospitalIncyte CorporationRecruitingPolycythemia Vera | Essential ThrombocythemiaUnited States
-
Incyte CorporationRecruitingAnemia | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, France, Italy, Japan, United Kingdom, Canada
-
Massachusetts General HospitalWashington University School of Medicine; Medical College of Wisconsin; Vanderbilt... and other collaboratorsRecruitingAcute Myeloid Leukemia | Allogeneic Stem Cell Transplantation | Acute Myeloid Leukemia in RemissionUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationActive, not recruitingLeukemia | Chronic Myelomonocytic LeukemiaUnited States
-
Yi-Lun WangCompletedSteroid Refractory GVHDTaiwan
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Celgene... and other collaboratorsCompletedIDH2 Mutation | Accelerated/Blast-phase Myeloproliferative Neoplasm | Chronic-phase MyelofibrosisUnited States, Canada